CELTIC

• Research type

  Research Study

• Full title

  Celtic Bifurcation Study A randomized multicentre trial to compare outcomes for patients with ischaemic heart disease and bifurcation coronary artery lesions who are treated with Xiences or Synergy stents

• IRAS ID

  163144

• Contact name

  Simon WALSH

• Contact email

  simon.j.walsh@btinternet.com

• Sponsor organisation

  CERIC

• Clinicaltrials.gov Identifier

  NCT02232815

• Duration of Study in the UK

  3 years, 2 months, 17 days

• Research summary

  Randomized, prospective, post-market, multicenter study performed in two countries where Synergy II and Xience Xpedition stents are CE approved. One hundred and seventy (170) consecutive patients are planned to be enrolled in up to nine participating investigational sites.

• REC name

  HSC REC A

• REC reference

  14/NI/1114

• Date of REC Opinion

  6 Nov 2014

• REC opinion

  Further Information Favourable Opinion